Collegium Pharmaceutical, Inc. (COLL) Q4 2023 Earnings Results

Collegium Pharmaceutical Beats on EPS, Stock Up 3.31%

Collegium Pharmaceutical reported a strong earnings per share figure, exceeding expectations by over 31%. This positive surprise contributed to a 3.31% increase in the stock price. However, without revenue figures or guidance updates, investors may have limited insight into the company's future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.58	N/A	+31.67%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for the earnings call, so the analysis is based solely on numerical results.

Collegium Pharmaceutical Beats on EPS, Stock Up 3.31%

Key numbers

Management commentary

Collegium Pharmaceutical, Inc.

More earnings this week

Collegium Pharmaceutical Beats on EPS, Stock Up 3.31%

Key numbers

Management commentary